Infectious Enteritis Treatment Market Size to Grow by USD 403.92 Million | Growth, Trends, and Forecasts (2022 - 2026)

Request a free sample report for additional information with exact growth variance and the Y-O-Y growth rate

Infectious Enteritis Treatment Market 2022-2026: Segmentation

• Geography
• North America
• Europe
• Asia
• Rest of World (ROW)

37% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for infectious enteritis treatment in North America. Market growth in this region will be faster than the growth of the market in Rest of World (ROW). The significant increase in foodborne illnesses in countries such as the US will facilitate the infectious enteritis treatment market growth in North America over the forecast period. 

• Route of Administration
• Oral
• Injectables

The infectious enteritis treatment market share growth by the oral segment will be significant during the forecast period. The rapid action of oral rehydration therapy on patients will drive the growth of the market in focus through this segment in the coming years. For instance, it has also been observed that zinc, in conjunction with ORS, is effective in reducing acute diarrhea by 15%-25%.

Request for a FREE sample to gain further insights on the market share & contribution of various regions & segments

Increasing Geriatric Population in Countries Such as Japan, Italy, and the US to Drive the Market Growth

For instance, according to the United Nations (UN) Department of Economic and Social Affairs, the population division of the geriatric population (persons aged 65 or over) was 702.9 million in 2019, which will become 727 million in 2020. Similarly, the geriatric population in India will increase by 41% over the next decade to touch 194 million in 2031. This increase in the percentage of the geriatric population around the globe is increasing the demand for the treatment of hospital-acquired infections around the world, which will work as a driver for the infectious enteritis treatment market during the forecast period.

Adverse Effects Associated with Infectious Enteritis Treatment to Challenge the Market Growth

Infectious enteritis causes diarrhea and associated fluid and electrolyte losses. Maldigestion and malabsorption are the dominant underlying pathophysiologic mechanisms; hence, intravenous therapy is more effective (at least initially) at correcting the electrolyte imbalances and fluid loss compared with oral administration. The crystalloids and colloids fluids should be considered as part of the fluid therapy. However, sometimes the treatment of infectious enteritis with these fluids or any other medication such as penicillin, cephalosporin, antifolate or sulfa combinations, nitroimidazole, glycopeptide, and monobactam antibiotics would further cause various side effects due to the historic allergy of the patients. Such factors are expected to negatively impact the market growth during the forecast period.

Download Free sample Report for insights on the Drivers, Trends, and Challenges that will help companies evaluate and develop growth strategies for 2022-2026

Our Infectious Enteritis Treatment Market Report Covers the Following Areas:

• Infectious Enteritis Treatment Market size
• Infectious Enteritis Treatment Market trends
• Infectious Enteritis Treatment Market analysis

Infectious Enteritis Treatment Market 2022-2026: Vendor Analysis

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

• Abbott Laboratories
• Almirall SA
• Cipla Ltd.
• Zydus Lifesciences Ltd.
• F. Hoffmann La Roche Ltd.
• Galderma SA
• GlaxoSmithKline Plc
• Hetero Healthcare Ltd.
• Mayne Pharma Group Ltd.
• Medimetriks Pharmaceuticals Inc.
• Merck KGaA
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Tolmar Pharmaceuticals Inc.
• Viatris Inc.

Moreover, the market is fragmented and the vendors are deploying growth strategies such as geographical expansion, product portfolio expansion, and product innovation to compete in the market.

Download Our FREE Sample Report for more vendor insights with product offerings & news

Infectious Enteritis Treatment Market 2022-2026: Key Highlights

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will assist infectious enteritis treatment market growth during the next five years
• Estimation of the infectious enteritis treatment market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the infectious enteritis treatment market
• Analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of infectious enteritis treatment market vendors

Related Reports:

Atherosclerosis Therapeutics Market by Product and Geography - Forecast and Analysis 2022-2026: The atherosclerosis therapeutics market share is expected to increase by USD 3.44 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.66%. To get more exclusive research insights: Download Our FREE Sample Report

Plasma Protease C1 Inhibitor Market by Product and Geography - Forecast and Analysis 2022-2026: The plasma protease C1 inhibitor market share is expected to increase by USD 1.7 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.4%. To get more exclusive research insights: Download Our FREE Sample Report

Table of Contents:

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Route of Administration
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers
• Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026

• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Route of Administration

• 5.1 Market segments
• Exhibit 24: Chart on Route of Administration - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Route of Administration - Market share 2021-2026 (%)

• 5.2 Comparison by Route of Administration
• Exhibit 26: Chart on Comparison by Route of Administration
• Exhibit 27: Data Table on Comparison by Route of Administration

• 5.3 Oral - Market size and forecast 2021-2026
• Exhibit 28: Chart on Oral - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Oral - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Oral - Year-over-year growth 2021-2026 (%)

• 5.4 Injectables - Market size and forecast 2021-2026
• Exhibit 32: Chart on Injectables - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Injectables - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Injectables - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Injectables - Year-over-year growth 2021-2026 (%)

• 5.5 Market opportunity by Route of Administration
• Exhibit 36: Market opportunity by Route of Administration ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 38: Chart on Market share by geography 2021-2026 (%)
• Exhibit 39: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison
• Exhibit 40: Chart on Geographic comparison
• Exhibit 41: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026
• Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 Germany - Market size and forecast 2021-2026
• Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 7.9 China - Market size and forecast 2021-2026
• Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)

• 7.10 UK - Market size and forecast 2021-2026
• Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)

• 7.11 Canada - Market size and forecast 2021-2026
• Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography
• Exhibit 78: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges
• Exhibit 79: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape
• Exhibit 80: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption
• Exhibit 81: Overview on factors of disruption

• 9.4 Industry risks
• Exhibit 82: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 83: Vendors covered

• 10.2 Market positioning of vendors
• Exhibit 84: Matrix on vendor position and classification

• 10.3 Abbott Laboratories
• Exhibit 85: Abbott Laboratories - Overview
• Exhibit 86: Abbott Laboratories - Business segments
• Exhibit 87: Abbott Laboratories - Key news
• Exhibit 88: Abbott Laboratories - Key offerings
• Exhibit 89: Abbott Laboratories - Segment focus

• 10.4 Almirall SA
• Exhibit 90: Almirall SA - Overview
• Exhibit 91: Almirall SA - Product / Service
• Exhibit 92: Almirall SA - Key news
• Exhibit 93: Almirall SA - Key offerings

• 10.5 Cipla Ltd.
• Exhibit 94: Cipla Ltd. - Overview
• Exhibit 95: Cipla Ltd. - Business segments
• Exhibit 96: Cipla Ltd. - Key news
• Exhibit 97: Cipla Ltd. - Key offerings
• Exhibit 98: Cipla Ltd. - Segment focus

• 10.6 F. Hoffmann La Roche Ltd.
• Exhibit 99: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 100: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 101: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 102: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 103: F. Hoffmann La Roche Ltd. - Segment focus

• 10.7 Galderma SA
• Exhibit 104: Galderma SA - Overview
• Exhibit 105: Galderma SA - Product / Service
• Exhibit 106: Galderma SA - Key news
• Exhibit 107: Galderma SA - Key offerings

• 10.8 GlaxoSmithKline Plc
• Exhibit 108: GlaxoSmithKline Plc - Overview
• Exhibit 109: GlaxoSmithKline Plc - Business segments
• Exhibit 110: GlaxoSmithKline Plc - Key news
• Exhibit 111: GlaxoSmithKline Plc - Key offerings
• Exhibit 112: GlaxoSmithKline Plc - Segment focus

• 10.9 Hetero Healthcare Ltd.
• Exhibit 113: Hetero Healthcare Ltd. - Overview
• Exhibit 114: Hetero Healthcare Ltd. - Product / Service
• Exhibit 115: Hetero Healthcare Ltd. - Key offerings

• 10.10 Medimetriks Pharmaceuticals Inc.
• Exhibit 116: Medimetriks Pharmaceuticals Inc. - Overview
• Exhibit 117: Medimetriks Pharmaceuticals Inc. - Product / Service
• Exhibit 118: Medimetriks Pharmaceuticals Inc. - Key offerings

• 10.11 Pfizer Inc.
• Exhibit 119: Pfizer Inc. - Overview
• Exhibit 120: Pfizer Inc. - Product / Service
• Exhibit 121: Pfizer Inc. - Key news
• Exhibit 122: Pfizer Inc. - Key offerings

• 10.12 Viatris Inc.
• Exhibit 123: Viatris Inc. - Overview
• Exhibit 124: Viatris Inc. - Business segments
• Exhibit 125: Viatris Inc. - Key offerings
• Exhibit 126: Viatris Inc. - Segment focus

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist
• Exhibit 127: Inclusions checklist
• Exhibit 128: Exclusions checklist

• 11.3 Currency conversion rates for US$
• Exhibit 129: Currency conversion rates for US$

• 11.4 Research methodology
• Exhibit 130: Research methodology
• Exhibit 131: Validation techniques employed for market sizing
• Exhibit 132: Information sources

• 11.5 List of abbreviations
• Exhibit 133: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio